The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jiang Wenbin since 2022.
This trader's CIK number is 1872873.
At the time of last reporting, Jiang Wenbin was the PRESIDENT AND CEO of Cytek Biosciences, Inc.. (stock ticker symbol CTKB).
Also see all insider trading activities at Cytek Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CTKB | 0 | $0 | 0 | $0 | 163,495 | $0 |
| 2024 | CTKB | 0 | $0 | 0 | $0 | 126,331 | $0 |
| 2023 | CTKB | 0 | $0 | 220,000 | $1,933,199 | 58,448 | $0 |
| 2022 | CTKB | 0 | $0 | 220,000 | $2,749,299 | 89,192 | $16,666 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | CTKB | Option Ex | 69,641 | .00 | 0 |
| 2025-05-19 | CTKB | Option Ex | 48,679 | .00 | 0 |
| 2025-03-10 | CTKB | Option Ex | 45,175 | .00 | 0 |
| 2024-11-18 | CTKB | Option Ex | 40,639 | .00 | 0 |
| 2024-08-19 | CTKB | Option Ex | 40,639 | .00 | 0 |
| 2024-05-20 | CTKB | Option Ex | 29,345 | .00 | 0 |
| 2024-03-11 | CTKB | Option Ex | 15,708 | .00 | 0 |
| 2023-11-18 | CTKB | Option Ex | 18,539 | .00 | 0 |
| 2023-11-07 | CTKB | Sale | 20,000 | 4.34 | 86,800 |
| 2023-10-09 | CTKB | Sale | 20,000 | 5.33 | 106,600 |
| 2023-09-07 | CTKB | Sale | 20,000 | 6.83 | 136,600 |
| 2023-08-18 | CTKB | Option Ex | 18,539 | .00 | 0 |
| 2023-08-07 | CTKB | Sale | 20,000 | 9.04 | 180,799 |
| 2023-07-07 | CTKB | Sale | 20,000 | 8.48 | 169,600 |
| 2023-06-07 | CTKB | Sale | 20,000 | 8.23 | 164,600 |
| 2023-05-18 | CTKB | Option Ex | 14,612 | .00 | 0 |
| 2023-05-08 | CTKB | Sale | 20,000 | 11.55 | 231,000 |
| 2023-04-10 | CTKB | Sale | 20,000 | 8.88 | 177,600 |
| 2023-03-07 | CTKB | Sale | 20,000 | 10.13 | 202,600 |
| 2023-02-21 | CTKB | Option Ex | 6,758 | .00 | 0 |
| 2023-02-07 | CTKB | Sale | 20,000 | 13.19 | 263,800 |
| 2023-01-09 | CTKB | Sale | 20,000 | 10.66 | 213,200 |
| 2022-12-07 | CTKB | Sale | 20,000 | 11.86 | 237,200 |
| 2022-11-18 | CTKB | Option Ex | 6,758 | .00 | 0 |
| 2022-11-07 | CTKB | Sale | 20,000 | 14.76 | 295,200 |
| 2022-10-07 | CTKB | Sale | 20,000 | 14.79 | 295,800 |
| 2022-09-07 | CTKB | Sale | 20,000 | 12.89 | 257,800 |
| 2022-08-18 | CTKB | Option Ex | 6,758 | .00 | 0 |
| 2022-08-08 | CTKB | Sale | 20,000 | 15.09 | 301,800 |
| 2022-07-07 | CTKB | Sale | 20,000 | 11.19 | 223,800 |
| 2022-06-07 | CTKB | Sale | 20,000 | 10.75 | 215,000 |
| 2022-05-18 | CTKB | Option Ex | 9,011 | .00 | 0 |
| 2022-05-09 | CTKB | Sale | 20,000 | 8.01 | 160,200 |
| 2022-04-07 | CTKB | Sale | 20,000 | 10.54 | 210,799 |
| 2022-03-04 | CTKB | Option Ex | 66,665 | .25 | 16,666 |
| 2022-03-07 | CTKB | Sale | 20,000 | 13.19 | 263,700 |
| 2022-02-07 | CTKB | Sale | 20,000 | 14.40 | 288,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jiang Wenbin (PRESIDENT AND CEO of Cytek Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.